BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8103215)

  • 1. Transmitter role of vasoactive intestinal peptide.
    Fahrenkrug J
    Pharmacol Toxicol; 1993 Jun; 72(6):354-63. PubMed ID: 8103215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VIP and autonomic neurotransmission.
    Fahrenkrug J
    Pharmacol Ther; 1989; 41(3):515-34. PubMed ID: 2541454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function.
    Fahrenkrug J
    Digestion; 1979; 19(3):149-69. PubMed ID: 39014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIP as a possible neurotransmitter of non-cholinergic non-adrenergic inhibitory neurones.
    Goyal RK; Rattan S; Said SI
    Nature; 1980 Nov; 288(5789):378-80. PubMed ID: 6107863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal polypeptide- and pituitary adenylate cyclase activating polypeptide-mediated control of catecholamine release from chromaffin tissue in the rainbow trout, Oncorhynchus mykiss.
    Montpetit CJ; Perry SF
    J Endocrinol; 2000 Sep; 166(3):705-14. PubMed ID: 10974664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasoactive intestinal polypeptide: a potential neurotransmitter].
    Zudenigo D; Lacković Z
    Lijec Vjesn; 1989; 111(9-10):354-9. PubMed ID: 2576679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The vasoactive intestinal polypeptide (VIP). Its role in the physiology of the digestive system].
    Leonardi R; Toffoli C; Rigamonti L; Rigamonti D; Gambassi G; Greco A; Ghirlanda G
    Minerva Med; 1981 Apr; 72(13):801-5. PubMed ID: 6111769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide: a transmitter in submucous neurons mediating secretion in guinea pig distal colon.
    Reddix R; Kuhawara A; Wallace L; Cooke HJ
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1124-9. PubMed ID: 7912276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against vasoactive intestinal polypeptide being the non-adrenergic, non-cholinergic inhibitory transmitter released from nerves supplying the smooth muscle of the guinea-pig taenia coli.
    Mackenzie I; Burnstock G
    Eur J Pharmacol; 1980 Oct; 67(2-3):255-64. PubMed ID: 6109636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal polypeptide (VIP): current status.
    Said SI
    Peptides; 1984; 5(2):143-50. PubMed ID: 6147814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
    Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
    Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal polypeptide as a neurotransmitter in the female genital tract.
    Ottesen B
    Am J Obstet Gynecol; 1983 Sep; 147(2):208-24. PubMed ID: 6137145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomic innervation of the human respiratory tract as revealed by histochemical and ultrastructural methods.
    Laitinen A
    Eur J Respir Dis Suppl; 1985; 140():1-42. PubMed ID: 2410288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion.
    Lundberg JM; Anggård A; Fahrenkrug J; Hökfelt T; Mutt V
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1651-5. PubMed ID: 6103537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide (VIP), a putative neurotransmitter of nonadrenergic, noncholinergic (NANC) inhibitory innervation and its relevance to therapy.
    Venugopalan CS
    J Vet Pharmacol Ther; 1989 Jun; 12(2):113-23. PubMed ID: 2568497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal polypeptide nerves in human upper respiratory tract.
    Uddman R; Sundler F
    ORL J Otorhinolaryngol Relat Spec; 1979; 41(4):221-6. PubMed ID: 388276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against VIP as the inhibitory transmitter in non-adrenergic, non-cholinergic nerves supplying the longitudinal muscle of the mouse colon.
    Fontaine J; Grivegnee AR; Robberecht P
    Br J Pharmacol; 1986 Nov; 89(3):599-602. PubMed ID: 2879596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurotransmitters of penile erection other than vasoactive intestinal polypeptide. Physiologic data and therapeutic consequences].
    Adaikan PG; Lau LC; Vasatha KS; Susheela K; Ratnam SS
    J Urol (Paris); 1990; 96(1):15-8. PubMed ID: 1968931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peptide VIP is a neurotransmitter in rat adrenal medulla: physiological role in controlling catecholamine secretion.
    Wakade TD; Blank MA; Malhotra RK; Pourcho R; Wakade AR
    J Physiol; 1991 Dec; 444():349-62. PubMed ID: 1688031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.